
Rohan Palekar, 89bio CEO
Updated: 89bio prices $150M public offering for PhIII development of NASH drug
89bio announced an upsized $150 million public offering of its common stock on Thursday, just a few days after the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.